Medical Advocates
Abacavir (Ziagen)
 
Perinatal Data

Prevention Treatment Guidelines
 General Reports
 Clinical Pharmacology







 
Abacavir Main Page Drugs Main Page Main New/Newsworthy Home Page    
Last Update:  November 23, 2007
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
ARV Treatment Guidelines
 
United States

          Internet Documents
 
 
FULL TEXT PDF DOCUMENT
 Public Health Service Task Force Recommendations for Use of Antiretroviral Drugs
in Pregnant HIV-Infected Women for Maternal Health and Interventions to Reduce
Perinatal HIV  Transmission in the United States.
Perinatal HIV Guidelines Working Group.
November 2, 2007
Guidelines
 
FULL TEXT PDF DOCUMENT
 Safety and Toxicity of Individual Antiretroviral Agents in Pregnancy
 Perinatal HIV Guidelines Working Group.
November 2, 2007
Guidelines
   
 
General Reports
 
        Conference Reports, Abstracts, and Posters
 
  Abacavir use in HIV-positive Pregnant Women
AM Puga, M L Brown, S M Widmayer
(14IAC)
Abstract
Clinical Pharmacology
 

Ex Vivo Studies

      Journal Papers, Abstracts, and Commentaries

  The ex vivo human placental transfer of the anti-HIV nucleoside inhibitor abacavir and the
protease inhibitor amprenavir.
Bawdon RE.
Infect Dis Obstet Gynecol 1998;6(6):244-6  
Abstract

Pharmacokinetics

     Journal Papers, Abstracts, and Commentaries
 
  Impact of pregnancy on abacavir pharmacokinetics.
 Best BM, Mirochnick M, Capparelli EV, et al  
AIDS. 2006 Feb 28;20(4):553-560.
Abstract

        Conference Reports, Abstracts, and Posters

  Preliminary Analysis of Abacavir Succinate (ABC) Pharmacokinetics in Neonates Differs from
Adults and Young Children
(7RETRO)
Abstract
 

Abacavir Main Page Drugs Main Page Main New/Newsworthy Home Page    

Abacavir Perinatal Data